| Income Statement |
| Operating Expenses | 18.11M |
|
| Research and Development Expense | 12.89M |
| Selling, General and Administrative Expense | 5.22M |
| Operating Income | -18.11M |
| Net Income | -16.64M |
| Net Income Common Stock | -16.64M |
| Net Income Common Stock (USD) | -16.64M |
| Consolidated Income | -16.64M |
| Earnings per Basic Share | -0.20 |
| Earnings per Basic Share (USD) | -0.20 |
| Earnings per Diluted Share | -0.20 |
| Earning Before Interest & Taxes (EBIT) | -16.64M |
| Earning Before Interest & Taxes (USD) | -16.64M |
| Weighted Average Shares | 82.89M |
| Weighted Average Shares Diluted | 82.89M |
| Balance Sheet |
| Cash and Equivalents | 85.23M |
| Cash and Equivalents (USD) | 85.23M |
| Investments | 104.75M |
| Investments Current | 104.75M |
| Current Assets | 192.41M |
| Property, Plant & Equipment Net | 1000 |
| Total Assets | 193.99M |
| Current Liabilities | 11.07M |
| Total Liabilities | 11.07M |
| Accumulated Retained Earnings (Deficit) | -392.08M |
| Accumulated Other Comprehensive Income | -63.00K |
| Shareholders Equity | 182.93M |
| Shareholders Equity (USD) | 182.93M |
| Assets Non-Current | 1.58M |
| Trade and Non-Trade Payables | 1.11M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1000 |
| Net Cash Flow from Financing | 81.84M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.44M |
| Issuance (Purchase) of Equity Shares | 81.93M |
| Net Cash Flow from Investing | -16.87M |
| Net Cash Flow - Investment Acquisitions and Disposals | -16.87M |
| Net Cash Flow from Operations | -14.53M |
| Share Based Compensation | 1.52M |